Henderson C A, Papworth-Smith J, Cunliffe W J, Highet A S, Shamy H K, Czarnetzki B M
Department of Dermatology, York District Hospital, U.K.
Br J Dermatol. 1989 Oct;121(4):493-6. doi: 10.1111/j.1365-2133.1989.tb15517.x.
In a double-blind trial of topical I,25-dihydroxycholecalciferol in 47 patients with psoriasis no benefit was shown compared with placebo.
在一项针对47名银屑病患者的局部使用1,25 - 二羟胆钙化醇的双盲试验中,与安慰剂相比未显示出益处。